Report Detail

Pharma & Healthcare Global Dermatophytic Onychomycosis Market Research Report 2019

  • RnM3086916
  • |
  • 09 March, 2019
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
The global dermatophytic onychomycosis market is intensely competitive owing to the presence of numerous small and large vendors that operate at a local or global scale. To survive and succeed in this market, the vendors enter into strategic alliances with smaller players to manufacture and market new drugs.
The Americas dominated this market and is envisaged to retain its dominating market position by the end of 2020 owing to the presence of a well-developed healthcare system

The global Dermatophytic Onychomycosis market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dermatophytic Onychomycosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dermatophytic Onychomycosis market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Anacor Pharmaceuticals
Galderma
Janssen Biotech
Novartis
Valeant Pharmaceuticals
Abeona Therapeutics
Allergan
Elorac
GlaxoSmithKline
Hexima
Hisamitsu Pharmaceutical
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharma
Moberg Pharma
NanoBio
NovaBiotics
Nuvo Research
Pfizer
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Taro Pharmaceutical
Topica Pharmaceuticals
Viamet Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Oral
Topical

Segment by Application
Hospitals
Clinics and laboratories
Others


Table of Contents

    Executive Summary

      1 Dermatophytic Onychomycosis Market Overview

      • 1.1 Product Overview and Scope of Dermatophytic Onychomycosis
      • 1.2 Dermatophytic Onychomycosis Segment by Type
        • 1.2.1 Global Dermatophytic Onychomycosis Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Topical
      • 1.3 Dermatophytic Onychomycosis Segment by Application
        • 1.3.1 Dermatophytic Onychomycosis Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics and laboratories
        • 1.3.4 Others
      • 1.4 Global Dermatophytic Onychomycosis Market by Region
        • 1.4.1 Global Dermatophytic Onychomycosis Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Dermatophytic Onychomycosis Market Size
        • 1.5.1 Global Dermatophytic Onychomycosis Revenue (2014-2025)
        • 1.5.2 Global Dermatophytic Onychomycosis Production (2014-2025)

      2 Global Dermatophytic Onychomycosis Market Competition by Manufacturers

      • 2.1 Global Dermatophytic Onychomycosis Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Dermatophytic Onychomycosis Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Dermatophytic Onychomycosis Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Dermatophytic Onychomycosis Production Sites, Area Served, Product Types
      • 2.5 Dermatophytic Onychomycosis Market Competitive Situation and Trends
        • 2.5.1 Dermatophytic Onychomycosis Market Concentration Rate
        • 2.5.2 Dermatophytic Onychomycosis Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Dermatophytic Onychomycosis Production Market Share by Regions

      • 3.1 Global Dermatophytic Onychomycosis Production Market Share by Regions
      • 3.2 Global Dermatophytic Onychomycosis Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Dermatophytic Onychomycosis Production
        • 3.4.1 North America Dermatophytic Onychomycosis Production Growth Rate (2014-2019)
        • 3.4.2 North America Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Dermatophytic Onychomycosis Production
        • 3.5.1 Europe Dermatophytic Onychomycosis Production Growth Rate (2014-2019)
        • 3.5.2 Europe Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Dermatophytic Onychomycosis Production (2014-2019)
        • 3.6.1 China Dermatophytic Onychomycosis Production Growth Rate (2014-2019)
        • 3.6.2 China Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Dermatophytic Onychomycosis Production (2014-2019)
        • 3.7.1 Japan Dermatophytic Onychomycosis Production Growth Rate (2014-2019)
        • 3.7.2 Japan Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Dermatophytic Onychomycosis Consumption by Regions

      • 4.1 Global Dermatophytic Onychomycosis Consumption by Regions
      • 4.2 North America Dermatophytic Onychomycosis Consumption (2014-2019)
      • 4.3 Europe Dermatophytic Onychomycosis Consumption (2014-2019)
      • 4.4 China Dermatophytic Onychomycosis Consumption (2014-2019)
      • 4.5 Japan Dermatophytic Onychomycosis Consumption (2014-2019)

      5 Global Dermatophytic Onychomycosis Production, Revenue, Price Trend by Type

      • 5.1 Global Dermatophytic Onychomycosis Production Market Share by Type (2014-2019)
      • 5.2 Global Dermatophytic Onychomycosis Revenue Market Share by Type (2014-2019)
      • 5.3 Global Dermatophytic Onychomycosis Price by Type (2014-2019)
      • 5.4 Global Dermatophytic Onychomycosis Production Growth by Type (2014-2019)

      6 Global Dermatophytic Onychomycosis Market Analysis by Applications

      • 6.1 Global Dermatophytic Onychomycosis Consumption Market Share by Application (2014-2019)
      • 6.2 Global Dermatophytic Onychomycosis Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Dermatophytic Onychomycosis Business

      • 7.1 Anacor Pharmaceuticals
        • 7.1.1 Anacor Pharmaceuticals Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.1.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.1.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Galderma
        • 7.2.1 Galderma Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.2.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.2.3 Galderma Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Janssen Biotech
        • 7.3.1 Janssen Biotech Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.3.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.3.3 Janssen Biotech Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Novartis
        • 7.4.1 Novartis Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.4.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.4.3 Novartis Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Valeant Pharmaceuticals
        • 7.5.1 Valeant Pharmaceuticals Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.5.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.5.3 Valeant Pharmaceuticals Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Abeona Therapeutics
        • 7.6.1 Abeona Therapeutics Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.6.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.6.3 Abeona Therapeutics Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Allergan
        • 7.7.1 Allergan Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.7.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.7.3 Allergan Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Elorac
        • 7.8.1 Elorac Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.8.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.8.3 Elorac Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GlaxoSmithKline
        • 7.9.1 GlaxoSmithKline Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.9.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.9.3 GlaxoSmithKline Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Hexima
        • 7.10.1 Hexima Dermatophytic Onychomycosis Production Sites and Area Served
        • 7.10.2 Dermatophytic Onychomycosis Product Introduction, Application and Specification
        • 7.10.3 Hexima Dermatophytic Onychomycosis Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Hisamitsu Pharmaceutical
      • 7.12 Mayne Pharma
      • 7.13 MediQuest Therapeutics
      • 7.14 Meiji Seika Pharma
      • 7.15 Merz Pharma
      • 7.16 Moberg Pharma
      • 7.17 NanoBio
      • 7.18 NovaBiotics
      • 7.19 Nuvo Research
      • 7.20 Pfizer
      • 7.21 Polichem
      • 7.22 Promius Pharma
      • 7.23 Sanofi
      • 7.24 Seren Pharmaceuticals
      • 7.25 Taro Pharmaceutical
      • 7.26 Topica Pharmaceuticals
      • 7.27 Viamet Pharmaceuticals

      8 Dermatophytic Onychomycosis Manufacturing Cost Analysis

      • 8.1 Dermatophytic Onychomycosis Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Dermatophytic Onychomycosis
      • 8.4 Dermatophytic Onychomycosis Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Dermatophytic Onychomycosis Distributors List
      • 9.3 Dermatophytic Onychomycosis Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Dermatophytic Onychomycosis Market Forecast

      • 11.1 Global Dermatophytic Onychomycosis Production, Revenue Forecast
        • 11.1.1 Global Dermatophytic Onychomycosis Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Dermatophytic Onychomycosis Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Dermatophytic Onychomycosis Price and Trend Forecast (2019-2025)
      • 11.2 Global Dermatophytic Onychomycosis Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Dermatophytic Onychomycosis Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Dermatophytic Onychomycosis Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Dermatophytic Onychomycosis Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Dermatophytic Onychomycosis Production, Revenue Forecast (2019-2025)
      • 11.3 Global Dermatophytic Onychomycosis Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Dermatophytic Onychomycosis Consumption Forecast (2019-2025)
        • 11.3.2 Europe Dermatophytic Onychomycosis Consumption Forecast (2019-2025)
        • 11.3.3 China Dermatophytic Onychomycosis Consumption Forecast (2019-2025)
        • 11.3.4 Japan Dermatophytic Onychomycosis Consumption Forecast (2019-2025)
      • 11.4 Global Dermatophytic Onychomycosis Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Dermatophytic Onychomycosis Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Dermatophytic Onychomycosis. Industry analysis & Market Report on Dermatophytic Onychomycosis is a syndicated market report, published as Global Dermatophytic Onychomycosis Market Research Report 2019. It is complete Research Study and Industry Analysis of Dermatophytic Onychomycosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $4,350.00
        $5,800.00
        2,279.40
        3,419.10
        4,558.80
        2,740.50
        4,110.75
        5,481.00
        450,080.00
        675,120.00
        900,160.00
        244,876.00
        367,314.00
        489,752.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report